The best price for compounded semaglutide is not always the lowest advertised monthly number. Compare the all-in cost, prescription review, refill policy, pharmacy type, shipping, dose-based price changes, and whether ongoing clinician support is included. At Chia, compounded semaglutide injection starts at $249/month after licensed-provider review, when appropriate.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →What is the best price for compounded semaglutide?
The best price is the lowest clear, complete price from a model that still includes medical review and safe pharmacy dispensing. For compounded semaglutide, a difference of $50 to $100 per month can matter, but only if you know what is included.
Semaglutide is a GLP-1 receptor agonist. It is the active ingredient in FDA-approved products including Ozempic for type 2 diabetes, Wegovy for chronic weight management, and Rybelsus as an oral semaglutide product for type 2 diabetes, each with its own labeled use 1, 2, 3. Compounded semaglutide is different: it is prepared by a compounding pharmacy for an individual prescription and is not FDA-approved 4, 5.
Why advertised prices can differ from the real monthly cost
A low ad price may only cover the vial or first month. The real cost may include a membership fee, refill visit, supplies, shipping, lab work, or a higher price at later dose levels. That is why we suggest comparing a full 12-month estimate when you can.
What all-in pricing should include
- Medication cost for the month
- Licensed clinician review before prescribing
- Follow-up messaging or visit access
- Refill process and refill timing
- Shipping and injection supplies, if applicable
- Any membership, lab, cancellation, or prepaid-plan fees
- Pharmacy disclosure, including whether the medication is prepared by a state-licensed 503A compounding pharmacy
How should patients compare compounded semaglutide prices?
Compare compounded semaglutide prices by looking at the total care model, not just the sticker price. A fair comparison includes the monthly price, whether the price changes over time, clinical support, pharmacy pathway, and refund or cancellation rules.
- 1Write down the starting monthly price and the expected ongoing monthly price.
- 2Ask whether the price changes with dose level or vial size.
- 3Check whether a membership fee is required.
- 4Check whether shipping, supplies, and refills are included.
- 5Ask how often a licensed clinician reviews progress and side effects.
- 6Confirm whether the pharmacy is disclosed and state-licensed.
- 7Read cancellation, refund, and prepaid-plan terms before paying.
Price also needs to be weighed against treatment planning. In the STEP 1 extension, weight regain occurred after semaglutide withdrawal, which supports talking with a clinician about long-term planning instead of choosing only by the cheapest first month 6. Side effects such as nausea, vomiting, diarrhea, constipation, abdominal pain, gallbladder problems, and rare serious risks are part of that planning and are listed in FDA-approved semaglutide labeling 1, 2, 3.
What should a semaglutide price comparison table include?
A useful semaglutide price table should show more than the first-month offer. It should make clear whether the price includes medication, clinician care, shipping, refills, and pharmacy transparency.
| Comparison point | Why it matters | What to look for |
|---|---|---|
| Provider or pharmacy model | Shows who reviews care and who prepares medication | Licensed clinician review plus a disclosed pharmacy pathway |
| Starting monthly price | Helps compare entry cost | The first month and what happens after it |
| Ongoing monthly price | Shows real budget impact | Month 2 onward, including refill costs |
| Prepaid plan requirements | Can lower the monthly average but reduce flexibility | Whether 3-, 6-, or 12-month payment is required |
| Dose-based price changes | Some programs charge more later | Whether the monthly price changes over time |
| Clinician review and messaging | GLP-1 care often needs side-effect and progress monitoring | Access to a licensed provider or care team |
| Compounding pharmacy disclosure | Helps avoid no-prescription or research-use products | State-licensed 503A pharmacy information |
| Important limitations | Prevents surprises | Shipping limits, state availability, cancellation rules, and refund terms |
For a deeper cost breakdown, see our guide to semaglutide price factors and our article on where to get semaglutide for less.
Why can compounded semaglutide cost less than brand-name Wegovy or Ozempic?
Wegovy and Ozempic are FDA-approved brand-name semaglutide products, while compounded semaglutide is prepared under compounding rules for an individual prescription. Cash-pay compounded pricing can be lower, but the products are not the same, and compounded formulations do not have FDA-evaluated outcomes data 4, 5.
Brand-name pricing reflects a branded drug supply chain, insurance contracts, manufacturer programs, and plan rules. Compounded medications follow a different path through state-licensed compounding pharmacies when legal and clinically appropriate. The FDA notes that compounded drugs are not FDA-approved and should not be described as having the same FDA review as approved drugs 5.
The active ingredient semaglutide has randomized human trial evidence in adults with overweight or obesity. In STEP 1, once-weekly semaglutide 2.4 mg was studied in adults with overweight or obesity and showed clinically meaningful weight loss, while gastrointestinal side effects were common and individual results varied 7. That evidence is for semaglutide as studied; it does not establish outcomes for every compounded formulation.
Which semaglutide is covered by insurance?
Insurance coverage depends on the exact product, diagnosis, plan formulary, and prior authorization rules. Wegovy, Ozempic, and Rybelsus have different labeled indications, so coverage is not the same across products 1, 2, 3.
- Wegovy coverage for chronic weight management may depend on body-mass criteria, related health conditions, prior authorization, and employer plan rules.
- Ozempic coverage is generally tied to type 2 diabetes indications and plan-specific rules.
- Rybelsus coverage is generally tied to type 2 diabetes indications and plan-specific rules.
- Compounded semaglutide is usually cash-pay, though patients should confirm with their insurer, pharmacy, and prescribing clinician.
Cost-effectiveness research also depends on payer assumptions, drug price, length of use, health outcomes, and comparator treatment, so a medication can look different from a patient budget view than from a health-system model 8.
Is the pill form of semaglutide cheaper?
Oral semaglutide exists as Rybelsus, an FDA-approved semaglutide tablet for type 2 diabetes, but it is not interchangeable with every injectable semaglutide use. Price depends on insurance, cash-pay pricing, dose, and diagnosis 3.
Injectable and oral semaglutide have different labeled uses, absorption, and clinical contexts. A licensed clinician can help compare options based on goals, medical history, current medications, side-effect risk, and whether a weight-management or diabetes indication is being considered.
How much more expensive is tirzepatide than semaglutide?
Tirzepatide is a dual GIP/GLP-1 receptor agonist; Zepbound and Mounjaro are FDA-approved tirzepatide products for their labeled uses 13, 14. Semaglutide and tirzepatide prices differ because they are different active ingredients, with different supply chains, insurance rules, and cash-pay care models.
At Chia, tirzepatide is available as compounded tablets from $249/month and compounded injection from $299/month, with microdosing plans available when clinically appropriate; compounded tirzepatide products are not FDA-approved. Chia’s compounded semaglutide injection starts at $249/month. A clinician may consider either option only after reviewing health history, goals, contraindications, and current medications.
| Option at Chia | Form | Current starting price | Notes |
|---|---|---|---|
| Semaglutide | Injection | From $249/month | Microdosing plans available when clinically appropriate |
| Tirzepatide | Tablets | From $249/month | Microdosing plans available when clinically appropriate |
| Tirzepatide | Injection | From $299/month | Microdosing plans available when clinically appropriate |
If you are comparing GLP-1 options more broadly, our guides to the best GLP-1 medications for weight loss and the best place to get tirzepatide online can help you frame the trade-offs.
3-min quiz
Considering compounded semaglutide?
Chia offers compounded semaglutide injection from $249/month after an online health questionnaire and licensed-provider review, when clinically appropriate. A prescription requires a medical evaluation and is never guaranteed. Compounded drugs are not FDA-approved.
Compounded semaglutide at Chia: injection, clinician review, and transparent starting price
At Chia, compounded semaglutide injection plans currently start at $249/month. We use a 100% online model: a short health questionnaire, licensed US provider review, prescribing only when clinically appropriate, and home delivery from US state-licensed 503A compounding pharmacies.
Microdosing plans are available when clinically appropriate. Dosing is provider-guided and may be adjusted over time. Patients can message their care team through the patient portal between visits.
You can start from the semaglutide product page or Chia’s eligibility quiz. If a GLP-1 plus energy-support approach is relevant to your goals, you can also read about Chia’s Weight + Energy protocol, which includes NAD+ injection plus a choice of GLP-1 when prescribed.
What safety checks matter before choosing the cheapest option?
The cheapest option is not always the safest or clearest option. For semaglutide, the most important safety checks are prescription status, licensed clinician review, side-effect monitoring, and a transparent pharmacy pathway.
- Avoid no-prescription semaglutide products or research-use products sold outside a medical relationship.
- Make sure a licensed clinician reviews medical history, medication list, pregnancy plans, pancreatitis history, gallbladder history, and other risk factors.
- Ask how side effects such as nausea, vomiting, diarrhea, constipation, abdominal pain, dehydration, and low blood sugar risk are monitored.
- Confirm whether the medication is dispensed through a state-licensed 503A compounding pharmacy when compounded medication is prescribed.
- Ask what happens if side effects occur, a refill is delayed, or treatment goals change.
The FDA has raised concerns about unapproved GLP-1 products used for weight loss, including dosing errors and products sold from unsafe sources 4. FDA compounding policy also makes clear that compounded drugs are not FDA-approved and are subject to different oversight than approved drug products 5.
Who may be eligible for semaglutide treatment?
Eligibility for semaglutide treatment cannot be decided by price alone. A licensed clinician reviews health history, current medications, goals, contraindications, and whether treatment is allowed under applicable law.
Semaglutide has been studied in several human randomized trials, including trials in obesity without diabetes and type 2 diabetes populations 7, 9, 10. Those studies also show why clinician oversight matters: benefits must be balanced with gastrointestinal side effects, medication interactions, contraindications, and long-term treatment planning.
A clinician may suggest semaglutide, another GLP-1 option, lifestyle treatment alone, or a different care plan. If you are comparing online options, our guide to online weight loss medication explains what to look for in prescription-based care.
What is the simplest checklist for finding a fair compounded semaglutide price?
A fair compounded semaglutide price is clear, complete, and tied to real clinical care. Before paying, use this checklist to compare programs side by side.
- Monthly price: What is the first-month price and the ongoing monthly price?
- 12-month cost: What would the total be if you stayed on treatment for a year?
- Dose changes: Does the price rise at higher dose levels?
- Clinician access: Is licensed-provider review included before prescribing?
- Messaging: Can you contact the care team between refills?
- Pharmacy: Is the dispensing pharmacy pathway clear?
- Shipping and supplies: Are they included or billed separately?
- Rules: Are cancellation, refund, and refill policies easy to understand?
- Safety: Does the provider screen for contraindications and side effects?
3-min quiz
Start with a licensed review
If you want to compare your options, Chia’s online visit starts with a health questionnaire reviewed by a licensed US provider. If compounded semaglutide is appropriate, plans currently start at $249/month and ship from a US state-licensed 503A compounding pharmacy. A prescription is not guaranteed, and compounded drugs are not FDA-approved.
FAQ
There is no single new price for semaglutide. Brand-name, insurance-covered, cash-pay, and compounded options can all differ. For compounded semaglutide, compare the ongoing monthly cost, membership fees, shipping, supplies, refill rules, and whether clinician care is included.
A fair monthly price is transparent and includes the care you need to use the medication safely: clinician review, pharmacy dispensing, refills, shipping details, and side-effect support. The lowest ad price may not be the lowest real cost if extra fees are added later.
Compounded semaglutide is usually cash-pay. Insurance coverage varies by plan, diagnosis, prior authorization rules, and formulary. Patients should confirm coverage directly with their insurer, pharmacy, and prescribing clinician.
No. Compounded semaglutide is not FDA-approved. FDA-approved semaglutide products include Ozempic, Wegovy, and Rybelsus for their labeled indications. Trial results for semaglutide as studied do not establish outcomes for every compounded formulation.
No. Semaglutide is a prescription-only medication. It should be used only under the guidance of a licensed healthcare professional who reviews whether it is appropriate for you.
Cheaper does not automatically mean unsafe, and expensive does not automatically mean better. The key is whether the program includes licensed clinician review, clear pharmacy sourcing, side-effect monitoring, refill support, and no no-prescription or research-use products.
No. Chia currently offers compounded semaglutide as an injection from $249/month. Chia does not currently offer a semaglutide pill.
Yes. Chia offers compounded tirzepatide tablets from $249/month and compounded tirzepatide injection from $299/month, with microdosing plans available when clinically appropriate; compounded tirzepatide products are not FDA-approved. A licensed provider decides whether any prescription option is appropriate after review.
References
- 1.U.S. Food and Drug Administration. Drugs@FDA: Ozempic (semaglutide) injection prescribing information. 2017.
- 2.U.S. Food and Drug Administration. Drugs@FDA: Wegovy (semaglutide) injection prescribing information. 2021.
- 3.U.S. Food and Drug Administration. Drugs@FDA: Rybelsus (semaglutide) tablets prescribing information. 2019.
- 4.U.S. Food and Drug Administration. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. 2026.
- 5.U.S. Food and Drug Administration. Compounding Laws and Policies. 2026.
- 6.Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism. 2022.
- 7.Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England Journal of Medicine. 2021.
- 8.Cost-effectiveness of Semaglutide Compared With Other Anti-Obesity Medications for Weight Loss. 2025.
- 9.Ryan DH, Lingvay I, Deanfield J, et al. Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial. Nature Medicine. 2024.
- 10.Marso SP, Bain SC, Consoli A, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. The New England Journal of Medicine. 2016.
- 11.Colhoun HM, Lingvay I, Brown PM, et al. Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial. Nature Medicine. 2024.
- 12.Garvey WT, Blücher M, Osorto Contreras CK, et al. Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity. The New England Journal of Medicine. 2025.
- 13.U.S. Food and Drug Administration. Drugs@FDA: Zepbound (tirzepatide) injection prescribing information. 2023.
- 14.U.S. Food and Drug Administration. Drugs@FDA: Mounjaro (tirzepatide) injection prescribing information. 2022.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
